Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Mohd Haider

Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement

Ampoule,And,Syringe,With,Needle,For,Mesotherapy.,Medical,Agent,,Drug,

Following the announcement of positive top-line results from its open-label Phase 2a trial, the stock of Aclaris Therapeutics Inc (NASDAQ:ACRS) has seen a 21.94% rise in after-hours trading on Tuesday.

Check out the current price of ACRS stock here. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.